FDA Inspection
Biocon Biosphere LimitedBiocon Biosphere Limited – FDA Inspection, Jun 14, 2024
Record Details
This FDA Inspection record concerns Biocon Biosphere Limited, with an inspection on June 14, 2024, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 1de125a7-6290-4603-b1d4-28f867088c0b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1241123
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.110(c)In-process materials characteristics testing
- 21 CFR 211.160(b)Scientifically sound laboratory controls
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biocon Biosphere Limited
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2025 | Not classified | Office of Inspections and Investigations |
Other documents for Biocon Biosphere Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.